Alteplase: resistance to use among ER physicians

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1489, 2005-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alteplase

By de Bono D.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 8, 1997-08 ,pp. : 1095-1098

Informa Healthcare

Access to resources Recommend Favorite

Translating alteplase use in stroke to clinical practice

Inpharma, Vol. 1, Iss. 1228, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

The use of complementary and alternative medicines (CAM) is high among children, and disclosure rates to physicians are low

Inpharma, Vol. 1, Iss. 1603, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Alteplase: A Review of Its Use in the Management of Acute Ischaemic Stroke

By Dhillon Sohita

CNS Drugs, Vol. 26, Iss. 10, 2012-10 ,pp. : 899-926

Adis International

Access to resources Recommend Favorite

Canadian study supports alteplase use outside tertiary care setting

Inpharma, Vol. 1, Iss. 1328, 2002-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite